Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.

PropertyValue
has major subject area list Antineoplastic Combined Chemotherapy Protocols; Kidney Neoplasms; Molecular Targeted Therapy

Search Criteria
  • Targeted Molecular Therapies